DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Aldeyra Therapeutics, Inc. (ALDX)
« Back to company indexALDX Chatter Timeline
Stock Ticker for ALDX
Most Active Tweeters for ALDX
No tweets foundRecent Tweets for ALDX
 |
@registrarjourn Aldeyra Therapeutics $ALDX Rating Reiterated by Canaccord Genuity https://t.co/z1qaencYtP August 20th 2018, 1:08pm |
 |
@EnterpriseLeade Aldeyra Therapeutics $ALDX Rating Reiterated by Canaccord Genuity https://t.co/2iwM0083r9 August 20th 2018, 1:08pm |
 |
@TheMarketsDaily Analysts Expect Aldeyra Therapeutics, Inc $ALDX Will Post Earnings of -$0.43 Per Share https://t.co/uvaR5q95Cd August 20th 2018, 11:08am |
 |
@mmahotstuff1 Aldeyra Therapeutics $ALDX Stock Price Up as Sentiment Improves - https://t.co/5wnaV0oHWT August 20th 2018, 8:08am |
 |
@whatsonthorold2 Institutional Investors Positive on Aldeyra Therapeutics $ALDX - https://t.co/xxJ44pThCs August 20th 2018, 8:08am |
 |
@west_moreland Institutional Investors Are Betting On Aldeyra Therapeutics $ALDX https://t.co/MhzblUxRtL August 20th 2018, 8:08am |
 |
@The_CasualSmart Institutional Investors Lead Shift in Aldeyra Therapeutics $ALDX Sentiment https://t.co/0vsZAHO0f6 August 20th 2018, 8:08am |
|
@registrarjourn Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/JJvoAjFm8M August 19th 2018, 9:08am |
 |
@MareaInformativ Reviewing BioXcel Therapeutics $BTAI and Aldeyra Therapeutics $ALDX https://t.co/5yRAQkM6uh August 18th 2018, 7:08pm |
|
@registrarjourn Head to Head Analysis: Aldeyra Therapeutics $ALDX versus BioXcel Therapeutics $BTAI https://t.co/iajvpzolS0 August 18th 2018, 7:08pm |
 |
@ThisLincolnian Zacks Investment Research Downgrades Aldeyra Therapeutics $ALDX to Sell https://t.co/2RKTJPzoRX August 18th 2018, 2:08pm |
 |
@OlympiaReport Aldeyra Therapeutics $ALDX Cut to Sell at Zacks Investment Research https://t.co/lkcORjpldo August 17th 2018, 6:08am |
 |
@WeekHerald Aldeyra Therapeutics $ALDX Cut to Sell at Zacks Investment Research https://t.co/teiMJOY3xY August 17th 2018, 6:08am |
|
@MareaInformativ -$0.43 EPS Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/L2hxeoTdIr August 17th 2018, 6:08am |
 |
@dakotafinancial -$0.43 EPS Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/PShPQfVtcx August 17th 2018, 6:08am |
 |
@AmericanBanking -$0.43 EPS Expected for Aldeyra Therapeutics, Inc $ALDX This Quarter https://t.co/6uozHaJqhf #stocks August 17th 2018, 6:08am |
 |
@4thQuarterCap Back in $ALDX August 16th 2018, 8:08am |
|
@registrarjourn Aldeyra Therapeutics $ALDX Upgraded at Zacks Investment Research https://t.co/CaFyQY8bJg August 16th 2018, 5:08am |
|
@EnterpriseLeade Aldeyra Therapeutics $ALDX Upgraded at Zacks Investment Research https://t.co/W3Ig5czhNO August 16th 2018, 5:08am |
 |
@dispatchtribune Aldeyra Therapeutics, Inc $ALDX Forecasted to Post FY2018 Earnings of -$1.76 Per Share https://t.co/4bdHJAbFhO August 16th 2018, 2:08am |
|
@OlympiaReport Aldeyra Therapeutics, Inc $ALDX Forecasted to Post FY2018 Earnings of -$1.76 Per Share https://t.co/BL5GVbPdDQ August 16th 2018, 2:08am |
|
@registrarjourn Aldeyra Therapeutics $ALDX Lowered to “Buy” at ValuEngine https://t.co/KEMHEwXOPR August 16th 2018, 12:08am |
|
@MareaInformativ Aldeyra Therapeutics $ALDX Downgraded by ValuEngine to Buy https://t.co/QG8Va2EH0G August 16th 2018, 12:08am |
|
@MareaInformativ Aldeyra Therapeutics, Inc $ALDX Receives $22.67 Average PT from Analysts https://t.co/FflDOa4R5N August 15th 2018, 12:08pm |
 |
@TickerReport Aldeyra Therapeutics $ALDX Stock Rating Lowered by Zacks Investment Research https://t.co/rOf7OYQMuh August 15th 2018, 11:08am |
 |
@WatchlistN Aldeyra Therapeutics $ALDX Lowered to Sell at Zacks Investment Research https://t.co/d2Cerpj2nT August 15th 2018, 11:08am |
|
@TheMarketsDaily FY2018 Earnings Forecast for Aldeyra Therapeutics, Inc $ALDX Issued By Cantor Fitzgerald https://t.co/k4vIqlOWoN August 15th 2018, 8:08am |
|
@AmericanBanking FY2018 Earnings Forecast for Aldeyra Therapeutics, Inc $ALDX Issued By Cantor Fitzgerald https://t.co/HVUQc3T92G #stocks August 15th 2018, 8:08am |
|
@TheMarketsDaily Zacks Investment Research Lowers Aldeyra Therapeutics $ALDX to Sell https://t.co/EUo10r4WRx August 14th 2018, 5:08pm |
|
@dakotafinancial Aldeyra Therapeutics $ALDX Given Buy Rating at Canaccord Genuity https://t.co/DlltXfoJHx August 14th 2018, 5:08am |
|
@dispatchtribune Aldeyra Therapeutics $ALDX Upgraded at ValuEngine https://t.co/fLazkCqJGv August 14th 2018, 5:08am |
|
@4thQuarterCap Sold $ALDX +12% August 14th 2018, 12:08am |
 |
@botpicks Should I Go Long or Short $ALDX ? August 13th 2018, 2:08pm |
|
@WatchlistN Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/OxOaTaPu5n August 13th 2018, 1:08pm |
|
@TickerReport Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/bBMhXJuMGV August 13th 2018, 1:08pm |
|
@registrarjourn Aldeyra Therapeutics’ $ALDX “Buy” Rating Reiterated at Canaccord Genuity https://t.co/z1qaencYtP August 13th 2018, 1:08pm |
|
@EnterpriseLeade Aldeyra Therapeutics’ $ALDX “Buy” Rating Reiterated at Canaccord Genuity https://t.co/2iwM0083r9 August 13th 2018, 1:08pm |
 |
@ConsumerFeed ValuEngine Upgrades Aldeyra Therapeutics $ALDX to Strong-Buy https://t.co/0jBJdsWJUw August 13th 2018, 11:08am |
|
@TheMarketsDaily Canaccord Genuity Reiterates “Buy” Rating for Aldeyra Therapeutics $ALDX https://t.co/dngaKIdypT August 12th 2018, 2:08pm |
 |
@TranscriptDaily Aldeyra Therapeutics $ALDX Receives “Buy” Rating from Canaccord Genuity https://t.co/Li54AoCi1a August 12th 2018, 2:08pm |
|
@The_CasualSmart Estabrook Capital Management Has Decreased Norfolk Southn $NSC Holding; Aldeyra Therapeutics $ALDX Sentiment Is 3 https://t.co/Xn7Bf1bFY6 August 12th 2018, 10:08am |
|
@EnterpriseLeade Cantor Fitzgerald Analysts Give Aldeyra Therapeutics $ALDX a $23.00 Price Target https://t.co/Y0W5YBp3ZH August 12th 2018, 9:08am |
|
@MareaInformativ Aldeyra Therapeutics $ALDX Stock Rating Upgraded by ValuEngine https://t.co/0NZ1LYyoMY August 12th 2018, 7:08am |
|
@dakotafinancial Aldeyra Therapeutics $ALDX Stock Rating Upgraded by ValuEngine https://t.co/zelqjWQPQ1 August 12th 2018, 5:08am |
|
@TickerReport ValuEngine Upgrades Aldeyra Therapeutics $ALDX to Strong-Buy https://t.co/vD5R26Srhr August 11th 2018, 5:08pm |
|
@WatchlistN Aldeyra Therapeutics $ALDX Upgraded to Strong-Buy at ValuEngine https://t.co/OINm8ADTUb August 11th 2018, 5:08pm |
|
@TheMarketsDaily Aldeyra Therapeutics $ALDX Issues Earnings Results, Misses Expectations By $0.03 EPS https://t.co/f3spywOnM6 August 11th 2018, 11:08am |
|
@TranscriptDaily Aldeyra Therapeutics $ALDX Given a $23.00 Price Target by Cantor Fitzgerald Analysts https://t.co/5ia14bzbiR August 11th 2018, 9:08am |
|
@MareaInformativ Aldeyra Therapeutics $ALDX PT Set at $23.00 by Cantor Fitzgerald https://t.co/wvvEgGdjYR August 11th 2018, 9:08am |
|
@MareaInformativ Aldeyra Therapeutics, Inc $ALDX Stake Boosted by Northern Trust Corp https://t.co/UALlx1N6Dv August 11th 2018, 6:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.